Literature DB >> 24292189

[Regulation of expression, function, and inflammatory responses of innate immune receptor Toll-like receptor-2 (TLR2) during inflammatory responses against infection].

Tsuyoshi Shuto1.   

Abstract

Toll-like receptor-2 (TLR2) is one of the important innate immune receptors that play an important role in recognizing the pathogens and producing inflammatory cytokines. In this review, we focus on the regulatory mechanisms of expression, function and inflammatory responses of TLR2 during pathogenic infection in innate immune cells. We first showed that nontypeable Haemophilus influenzae (NTHi), an important human pathogen that exacerbates otitis media and chronic obstructive pulmonary diseases (COPD), induces inflammatory responses through activation of NF-κB via two distinct signals, NIK-IKKα/β-IκBα and MKK3/6-p38 pathways. Moreover, TLR2 was greatly up-regulated by NTHi through the positive IKK-IκBα-dependent NF-κB pathway and the negative MKK3/6-p38α/β pathway. Importantly, glucocorticoids synergistically enhance NTHi-induced TLR2 up-regulation likely via a negative cross-talk with the inhibitory p38 MAPK. The results provide novel insights into the role of glucocorticoids in regulating host defense and innate immune responses through TLR2 regulation. We next focused on the pathogenesis of cystic fibrosis (CF), a common lethal inherited disorder characterized by recurrent pulmonary infections and obstruction caused by chronic mucus hypersecretion and inflammation. We demonstrated an increased expression of TLR2, due to an enhanced DNA de-methylation and Sp1-dependent transcriptional activation in CF epithelial cells. Furthermore, a Th17 cytokine IL-17A synergistically increased TLR2 signal through an enhancement of p38 phosphorylation. These studies suggest the importance of TLR2 and IL-17 signals in the pathogenesis of CF. Finally, by focusing on neutrophils and CF airway epithelial cells, we identified curcumin as a potent inhibitor of TLR2-mediated inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24292189     DOI: 10.1248/yakushi.13-00208

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  4 in total

Review 1.  Pathogenic Triad in Bacterial Meningitis: Pathogen Invasion, NF-κB Activation, and Leukocyte Transmigration that Occur at the Blood-Brain Barrier.

Authors:  Shifu Wang; Liang Peng; Zhongtao Gai; Lehai Zhang; Ambrose Jong; Hong Cao; Sheng-He Huang
Journal:  Front Microbiol       Date:  2016-02-19       Impact factor: 5.640

Review 2.  Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus.

Authors:  R Gasparini; D Amicizia; P L Lai; N L Bragazzi; D Panatto
Journal:  J Prev Med Hyg       Date:  2014-12

Review 3.  Progress of small molecular inhibitors in the development of anti-influenza virus agents.

Authors:  Xiaoai Wu; Xiuli Wu; Qizheng Sun; Chunhui Zhang; Shengyong Yang; Lin Li; Zhiyun Jia
Journal:  Theranostics       Date:  2017-02-08       Impact factor: 11.556

4.  The effects of nano-curcumin as a nutritional strategy on clinical and inflammatory factors in children with cystic fibrosis: the study protocol for a randomized controlled trial.

Authors:  Saeedeh Talebi; Mahammad Safarian; Mahmood Reza Jaafari; Seyed Javad Sayedi; Zahra Abbasi; Golnaz Ranjbar; Hamid Reza Kianifar
Journal:  Trials       Date:  2021-04-20       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.